<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"><channel><title>Trump administration will allow pharmacies to make popular peptides — Live Feed</title><link>https://www.live-feeds.com/feed/trump-administration-will-allow-pharmacies-to-make-popular-peptides</link><atom:link xmlns:atom="http://www.w3.org/2005/Atom" href="https://www.live-feeds.com/feed/trump-administration-will-allow-pharmacies-to-make-popular-peptides/rss.xml" rel="self" type="application/rss+xml"/><description>Continuously updated, source-cited coverage.</description>
<item><title>HHS Allows Pharmacies to Make Popular Unapproved Peptides</title><link>https://www.live-feeds.com/feed/trump-administration-will-allow-pharmacies-to-make-popular-peptides</link><guid isPermaLink="false">https://www.live-feeds.com/feed/trump-administration-will-allow-pharmacies-to-make-popular-peptides#u174262</guid><pubDate>Wed, 04 Nov 2026 13:20:11 +0000</pubDate><description>The Department of Health and Human Services released a policy allowing small compounding pharmacies to make six popular peptides without Food and Drug Administration approval. Health and Human Services Secretary Robert F. Kennedy Jr. championed the move to expand access to the unapproved peptide injections, overriding agency scientists who opposed the policy. The Department of Health and Human Services stated that the policy does not establish clinical safety and effectiveness. The decision represents a major win for peptide proponents and health freedom advocates seeking wider availability of</description></item>
</channel></rss>